Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia

While the clinical impact of mutations in the ABL1 gene on response to therapy in chronic phase chronic myeloid leukemia (CP-CML) is well established, less is known about how other mutations affect prognosis. In a retrospective analysis, we identified 115 patients with CML (71 chronic, 15 accelerate...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidikian, Aram, Kantarjian, Hagop, Jabbour, Elias, Short, Nicholas J., Patel, Keyur, Ravandi, Farhad, Sasaki, Koji, Issa, Ghayas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616867/
https://www.ncbi.nlm.nih.gov/pubmed/36307398
http://dx.doi.org/10.1038/s41408-022-00742-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616867/
https://www.ncbi.nlm.nih.gov/pubmed/36307398
http://dx.doi.org/10.1038/s41408-022-00742-1

Ejemplares similares